Masaki Iino

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

Future oncology (London, England)

Hematology (Amsterdam, Netherlands)

Annals of hematology

International journal of hematology

Yamanashi Prefectural Central Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yamanashi Prefectural Central Hospital Feb 15 2019

Japan

Professor :: Hematology and Hematopoietic stem cell transplantation

Publications

Yu Abe, Shiro Kubonishi, Masaki Ri, Masaki Iino, Kazutaka Sunami, Tomoki Ito, Masafumi Fukaya, Toshiyuki Kitano, Sho Ikeda, Shuichi Ota, Taiga Kuroi, Noriyoshi Iriyama, Tatsuro Jo, Masaaki Adachi, Daigo Akahane, Tatsuyuki Kai, Yoichi Kohara, Norimitsu Kadowaki, Teruaki Katayama
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future oncology (London, England) (2024)
Yu Abe, Shiro Kubonishi, Masaki Ri, Masaki Iino, Kazutaka Sunami, Tomoki Ito, Masafumi Fukaya, Toshiyuki Kitano, Sho Ikeda, Shuichi Ota, Taiga Kuroi, Noriyoshi Iriyama, Tatsuro Jo, Masaaki Adachi, Daigo Akahane, Tatsuyuki Kai, Yoichi Kohara, Norimitsu Kadowaki, Teruaki Katayama
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future oncology (London, England) (2024)
Yu Abe, Shiro Kubonishi, Masaki Ri, Masaki Iino, Kazutaka Sunami, Tomoki Ito, Masafumi Fukaya, Toshiyuki Kitano, Sho Ikeda, Shuichi Ota, Taiga Kuroi, Noriyoshi Iriyama, Tatsuro Jo, Masaaki Adachi, Daigo Akahane, Tatsuyuki Kai, Yoichi Kohara, Norimitsu Kadowaki, Teruaki Katayama
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future oncology (London, England) 20 (17) (2024)
Yu Abe, Shiro Kubonishi, Masaki Ri, Masaki Iino, Kazutaka Sunami, Tomoki Ito, Masafumi Fukaya, Toshiyuki Kitano, Sho Ikeda, Shuichi Ota, Taiga Kuroi, Noriyoshi Iriyama, Tatsuro Jo, Masaaki Adachi, Daigo Akahane, Tatsuyuki Kai, Yoichi Kohara, Norimitsu Kadowaki, Teruaki Katayama
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future oncology (London, England) 20 (17) (2024)
Yasunori Kogure, Hiroshi Handa, Yuta Ito, Masaki Ri, Yuichi Horigome, Masaki Iino, Yoriko Harazaki, Takahiro Kobayashi, Masahiro Abe, Tadao Ishida, Shigeki Ito, Hiromi Iwasaki, Junya Kuroda, Hirohiko Shibayama, Kazutaka Sunami, Hiroyuki Takamatsu, Hideto Tamura, Toshiaki Hayashi, Kiwamu Akagi, Tomohiro Shinozaki, Takahiro Yoshida, Ikuo Mori, Shinsuke Iida, Takahiro Maeda, Keisuke Kataoka
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone. Blood 143 (23) (2024)
Yu Abe, Shiro Kubonishi, Masaki Ri, Masaki Iino, Kazutaka Sunami, Tomoki Ito, Masafumi Fukaya, Toshiyuki Kitano, Sho Ikeda, Shuichi Ota, Taiga Kuroi, Noriyoshi Iriyama, Tatsuro Jo, Masaaki Adachi, Daigo Akahane, Tatsuyuki Kai, Yoichi Kohara, Norimitsu Kadowaki, Teruaki Katayama
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future oncology (London, England) 20 (17) (2024)
Masaki Iino, Atsushi Jinguji, Tomoya Sato, Ayato Nakadate
Real-world experience of treatment with thrombopoietin receptor agonists in anti-thymocyte globulin-naïve patients with aplastic anemia: an observational retrospective analysis in a single institution. Hematology (Amsterdam, Netherlands) 27 (1) (2022)
Masaki Iino, Tomoya Sato, Ayato Nakadate, Tomoya Onuki, Nobuyuki Takayama
Forodesine maintenance therapy for newly diagnosed peripheral T-cell lymphoma: a single-institutional, observational, retrospective analysis. Annals of hematology 101 (10) (2022)
Katsuhiro Miura, Hideki Tsujimura, Yasufumi Masaki, Masaki Iino, Jun Takizawa, Yoshinobu Maeda, Kazuhiko Yamamoto, Shinobu Tamura, Akiyo Yoshida, Hideo Yagi, Isao Yoshida, Koichi Kitazume, Taro Masunari, Ilseung Choi, Yasutaka Kakinoki, Ritsuro Suzuki, Tadashi Yoshino, Shigeo Nakamura, Yoshihiro Hatta, Takashi Yoshida, Masatoshi Kanno
Consolidation with 90 Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma. Hematological oncology 39 (1) (2020)
Masaki Iino, Yuma Sakamoto, Tomoya Sato
Yttrium-90 ibritumomab tiuxetan consolidation versus rituximab maintenance therapy after induction chemotherapy in patients with indolent non-Hodgkin lymphoma: a single-institution experience. Hematology (Amsterdam, Netherlands) 24 (1) (2020)
Masaki Iino, Yuma Sakamoto, Tomoya Sato
Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practice. International journal of hematology 112 (2) (2020)
Masaki Iino, Takeo Yamamoto, Yuma Sakamoto
Outcomes of unplanned tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: retrospective analysis of real-world experience in a single institution. Hematology (Amsterdam, Netherlands) 24 (1) (2019)

Masaki Iino.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masaki Iino